참고문헌
- Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-578 https://doi.org/10.1056/NEJMoa053422
- Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008;371:1695-1709 https://doi.org/10.1016/S0140-6736(08)60728-X
- Chiesa F, Mauri S, Tradati N, Calabrese L, Giugliano G, Ansarin M, et al. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol 1999;35:590-596 https://doi.org/10.1016/S1368-8375(99)00043-3
- Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571-578 https://doi.org/10.1016/S0360-3016(01)01690-X
- Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006;28:107-113 https://doi.org/10.1002/hed.20309
- Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 2003;9:112-118 https://doi.org/10.1034/j.1601-0825.2003.01750.x
- Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000;110:1-18 https://doi.org/10.1097/00005537-200003001-00001
- Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF Jr, Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 2000;22:207-214 https://doi.org/10.1002/(SICI)1097-0347(200005)22:3<207::AID-HED1>3.0.CO;2-9
- Matoba M, Tuji H, Shimode Y, Toyoda I, Kuginuki Y, Miwa K, et al. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. AJNR Am J Neuroradiol 2014;35:379-385 https://doi.org/10.3174/ajnr.A3706
- Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR. Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 1997;106:117-122 https://doi.org/10.1177/000348949710600205
- Lavertu P, Bonafede JP, Adelstein DJ, Saxton JP, Strome M, Wanamaker JR, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406 https://doi.org/10.1001/archotol.124.4.401
- Davuluri R, Krase JM, Cui H, Goyal UD, Cheung MK, Hsu CC, et al. Image guided volumetric response during chemoradiotherapy for head and neck squamous cell carcinoma as a predictor of disease outcomes. Am J Otolaryngol 2016;37:304-310 https://doi.org/10.1016/j.amjoto.2016.03.003
- Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, et al. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral Oncol 2015;51:195-201 https://doi.org/10.1016/j.oraloncology.2014.11.001
- Belli ML, Fiorino C, Zerbetto F, Raso R, Broggi S, Chiara A, et al. Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy. Acta Oncol 2015;54:1490-1495 https://doi.org/10.3109/0284186X.2015.1062137
- Ojiri H, Mendenhall WM, Mancuso AA. CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys 2002;52:748-754 https://doi.org/10.1016/S0360-3016(01)02671-2
- Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology 2000;214:683-687 https://doi.org/10.1148/radiology.214.3.r00fe13683
- King AD, Keung CK, Yu KH, Mo FK, Bhatia KS, Yeung DK, et al. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34:1237-1241 https://doi.org/10.3174/ajnr.A3378
- Lell M, Baum U, Greess H, Nomayr A, Nkenke E, Koester M, et al. Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 2000;33:239-247 https://doi.org/10.1016/S0720-048X(99)00120-5
- Sanguineti G, Ricchetti F, Wu B, Agrawal N, Gourin C, Agbahiwe H, et al. Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy. Head Neck 2012;34:1640-1647 https://doi.org/10.1002/hed.21981
- Munck JN, Cvitkovic E, Piekarski JD, Benhamou E, Recondo G, Bachouchi M, et al. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. J Natl Cancer Inst 1991;83:569-575 https://doi.org/10.1093/jnci/83.8.569
- McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 2004;26:890-896 https://doi.org/10.1002/hed.20080
- King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20:2213-2220 https://doi.org/10.1007/s00330-010-1769-8
- Srinivasan A, Chenevert TL, Dwamena BA, Eisbruch A, Watcharotone K, Myles JD, et al. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr 2012;36:131-137 https://doi.org/10.1097/RCT.0b013e3182405435
- Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, et al. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 2014;9:e115933
- Marzi S, Piludu F, Sanguineti G, Marucci L, Farneti A, Terrenato I, et al. The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging. Eur J Radiol 2017;92:93-102 https://doi.org/10.1016/j.ejrad.2017.05.002
- Lombardi M, Cascone T, Guenzi E, Stecco A, Buemi F, Krengli M, et al. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma. Radiol Med 2017;122:345-352 https://doi.org/10.1007/s11547-017-0733-y
- Lambrecht M, Van Calster B, Vandecaveye V, De Keyzer F, Roebben I, Hermans R, et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 2014;110:429-434 https://doi.org/10.1016/j.radonc.2014.01.004
- Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986-994 https://doi.org/10.1158/1078-0432.CCR-08-1287
- Hauser T, Essig M, Jensen A, Gerigk L, Laun FB, Munter M, et al. Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results. Neuroradiology 2013;55:527-536 https://doi.org/10.1007/s00234-013-1154-9
- Hatakenaka M, Shioyama Y, Nakamura K, Yabuuchi H, Matsuo Y, Sunami S, et al. Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy. AJNR Am J Neuroradiol 2011;32:1904-1910 https://doi.org/10.3174/ajnr.A2610
- Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Ohnishi K, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:339-345 https://doi.org/10.1016/j.ijrobp.2010.05.051
- Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Kamitani T, et al. Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy. Jpn J Radiol 2014;32:80-89 https://doi.org/10.1007/s11604-013-0272-y
- Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012;82:1098-1107 https://doi.org/10.1016/j.ijrobp.2011.02.044
- King AD, Chow KK, Yu KH, Mo FK, Yeung DK, Yuan J, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013;266:531-538 https://doi.org/10.1148/radiol.12120167
- Wong KH, Panek R, Welsh L, McQuaid D, Dunlop A, Riddell A, et al. The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/CT and diffusion-weighted mri for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 2016;57:1843-1850 https://doi.org/10.2967/jnumed.116.174433
- Schouten CS, de Bree R, van der Putten L, Noij DP, Hoekstra OS, Comans EF, et al. Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during chemoradiotherapy in advanced head and neck cancer. Quant Imaging Med Surg 2014;4:239-250
- Paudyal R, Oh JH, Riaz N, Venigalla P, Li J, Hatzoglou V, et al. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma. J Magn Reson Imaging 2017;45:1013-1023 https://doi.org/10.1002/jmri.25523
- Galban CJ, Mukherji SK, Chenevert TL, Meyer CR, Hamstra DA, Bland PH, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2:184-190 https://doi.org/10.1593/tlo.09175
- Aramburu Nunez D, Lopez MA, Mera IM, Salvador GF, Dave A, Hatzoglou V, et al. Multimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience. World J Radiol 2017;9:17-26 https://doi.org/10.4329/wjr.v9.i1.17
- Hauser T, Essig M, Jensen A, Laun FB, Munter M, Maier-Hein KH, et al. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: evaluation of lymph node metastasis. Eur J Radiol 2014;83:783-787 https://doi.org/10.1016/j.ejrad.2014.02.013
- Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-536 https://doi.org/10.7326/0003-4819-155-8-201110180-00009
- Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9
- Vandecaveye V, Dirix P, De Keyzer F, de Beeck KO, Vander Poorten V, Roebben I, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20:1703-1714 https://doi.org/10.1007/s00330-010-1734-6
- King AD, Thoeny HC. Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging 2016;16:23
- Driessen JP, Caldas-Magalhaes J, Janssen LM, Pameijer FA, Kooij N, Terhaard CH, et al. Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 2014;272:456-463 https://doi.org/10.1148/radiol.14131173
- Driessen JP, van Bemmel AJ, van Kempen PM, Janssen LM, Terhaard CH, Pameijer FA, et al. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas. Head Neck 2016;38 Suppl 1:E613-E618 https://doi.org/10.1002/hed.24051
- Nakahira M, Saito N, Yamaguchi H, Kuba K, Sugasawa M. Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014;271:1219-1225 https://doi.org/10.1007/s00405-013-2641-7
- Abdel Razek AA, Kandeel AY, Soliman N, El-shenshawy HM, Kamel Y, Nada N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007;28:1146-1152 https://doi.org/10.3174/ajnr.A0491
- Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24:843-847 https://doi.org/10.1016/j.mri.2005.11.005
- Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Kohler G, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006;41:618-623 https://doi.org/10.1097/01.rli.0000225398.17315.68
- Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003;21:1094-1100 https://doi.org/10.1200/JCO.2003.05.069
- Chen YG, Chen MQ, Guo YY, Li SC, Wu JX, Xu BH. Apparent diffusion coefficient predicts pathology complete response of rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2016;11:e0153944
- Onal C, Erbay G, Guler OC. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy. J Magn Reson Imaging 2016;44:1010-1019 https://doi.org/10.1002/jmri.25215
- Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455 https://doi.org/10.1002/hed.10394
- Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-1423 https://doi.org/10.1016/j.ijrobp.2003.09.004
- Lopez Rodriguez M, Cerezo Padellano L, Martin Martin M, Counago Lorenzo F. Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer. Clin Transl Oncol 2008;10:812-816 https://doi.org/10.1007/s12094-008-0294-6
- Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505 https://doi.org/10.1148/radiology.168.2.3393671